-
Product Insights
NewHypersomnia – Drugs In Development, 2024
Empower your strategies with our Hypersomnia – Drugs In Development, 2024 report and make more profitable business decisions. Hypersomnia is a neurological disorder of excessive time spent sleeping or excessive sleepiness. It can have many possible causes (such as seasonal affective disorder) and can cause distress and problems with functioning. It is a pathological state characterized by a lack of alertness during the waking episodes of the day. The main symptom of hypersomnia is excessive daytime sleepiness (EDS), or prolonged nighttime...
-
Product Insights
NewLewy Body Dementia – Drugs In Development, 2024
Empower your strategies with our Lewy Body Dementia – Drugs In Development, 2024 report and make more profitable business decisions. Lewy body dementia (LBD) is a progressive neurodegenerative disorder characterized by the abnormal accumulation of alpha-synuclein protein deposits (Lewy bodies) in the brain. This condition shares similarities with both Alzheimer's disease and Parkinson's disease, presenting a complex spectrum of symptoms that affect cognition, movement, behavior, and autonomic functions. LBD manifests through various symptoms that may fluctuate in severity, including cognitive changes...
-
Product Insights
NewAttention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2024
Empower your strategies with our Attention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2024 report and make more profitable business decisions. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics. The Attention Deficit Hyperactivity Disorder (ADHD) drugs in development market research report provide comprehensive information on the therapeutics under development for Attention...
-
Product Insights
NewOpium (Opioid) Addiction – Drugs In Development, 2024
Empower your strategies with our Opium (Opioid) Addiction – Drugs In Development, 2024 report and make more profitable business decisions. Opioid addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers, known as endorphins). This can lead to an inability of the body to stop pain, because there are no endorphins to mask the pain initially. The degeneration...
-
Product Insights
NewAutism Spectrum Disorder (ASD) – Drugs In Development, 2024
Empower your strategies with our Autism Spectrum Disorder (ASD) – Drugs In Development, 2024 report and make more profitable business decisions. Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction, communication, and repetitive behaviors. Symptoms range from mild to severe, forming a spectrum. Individuals with ASD may have difficulties in understanding social cues, expressing emotions, and engaging in reciprocal conversations. Sensory sensitivities are common, affecting responses to stimuli. Early intervention and tailored support can enhance communication...
-
Product Insights
Shell Knijpe Solar PV Park
Shell Knijpe Solar PV Park is a solar PV project located in Friesland, Netherlands. The project is owned by Shell New Energies NL BV and was developed by Anesco Ltd; Shell New Energies NL BV. The project came online in 2020. Empower your strategies with our Shell Knijpe Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Shell Emmen Solar PV Park
Shell Emmen Solar PV Park is a solar PV project located in Drenthe, Netherlands. The project is owned by Shell New Energies NL BV and was developed by Anesco Ltd; Shell New Energies NL BV. The project came online in 2020. Empower your strategies with our Shell Emmen Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Track & Monitor
Consumer Goods Venture Capital Investments in Q3 2023
GlobalData's Consumer Goods VentureView report provides detailed coverage of the global venture capital investment activity in Consumer Goods industry in Q3 2023, covering key insights and trends.
-
Product Insights
Shell New Energies Sas Van Gent Solar PV Park
Shell New Energies Sas Van Gent Solar PV Park is a solar PV project located in Zeeland, Netherlands. The project is owned by Shell New Energies NL BV and was developed by Shell New Energies NL BV; Solar Energy Works BV. The project came online in 2022. Empower your strategies with our Shell New Energies Sas Van Gent Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request....
-
Product Insights
Cassini Project
The Cassini Project is a nickel mine in Australia. It is currently in operation. Empower your strategies with our Cassini Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...